Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

BUY
$1.16 - $2.42 $638 - $1,331
550 New
550 $0
Q4 2021

Jan 14, 2022

SELL
$3.17 - $4.09 $61,390 - $79,206
-19,366 Closed
0 $0
Q3 2021

Oct 13, 2021

SELL
$3.01 - $3.77 $10,805 - $13,534
-3,590 Reduced 15.64%
19,366 $69,000
Q2 2021

Jul 20, 2021

SELL
$2.86 - $3.61 $68,239 - $86,134
-23,860 Reduced 50.97%
22,956 $73,000
Q1 2021

Apr 15, 2021

SELL
$2.61 - $4.08 $57,028 - $89,148
-21,850 Reduced 31.82%
46,816 $161,000
Q4 2020

Jan 28, 2021

SELL
$1.82 - $2.61 $56,647 - $81,236
-31,125 Reduced 31.19%
68,666 $173,000
Q3 2020

Oct 07, 2020

SELL
$2.02 - $3.02 $11,358 - $16,981
-5,623 Reduced 5.33%
99,791 $210,000
Q2 2020

Jul 07, 2020

SELL
$2.12 - $3.22 $162,394 - $246,655
-76,601 Reduced 42.08%
105,414 $236,000
Q1 2020

Apr 06, 2020

SELL
$1.82 - $3.87 $9,636 - $20,491
-5,295 Reduced 2.83%
182,015 $460,000
Q4 2019

Jan 15, 2020

SELL
$2.57 - $3.68 $23,127 - $33,116
-8,999 Reduced 4.58%
187,310 $493,000
Q3 2019

Oct 08, 2019

SELL
$3.01 - $4.0 $6,727 - $8,940
-2,235 Reduced 1.13%
196,309 $707,000
Q2 2019

Jul 10, 2019

SELL
$2.79 - $4.31 $53,732 - $83,006
-19,259 Reduced 8.84%
198,544 $669,000
Q1 2019

Apr 03, 2019

SELL
$2.54 - $4.02 $15,189 - $24,039
-5,980 Reduced 2.67%
217,803 $595,000
Q4 2018

Jan 09, 2019

SELL
$2.46 - $4.2 $261,522 - $446,502
-106,310 Reduced 32.21%
223,783 $622,000
Q3 2018

Oct 11, 2018

SELL
$3.81 - $5.53 $59,824 - $86,832
-15,702 Reduced 4.54%
330,093 $1.36 Million
Q2 2018

Jul 09, 2018

BUY
$5.06 - $6.78 $186,800 - $250,297
36,917 Added 11.95%
345,795 $1.79 Million
Q1 2018

Apr 06, 2018

BUY
$5.43 - $8.36 $350,691 - $539,922
64,584 Added 26.44%
308,878 $1.69 Million
Q4 2017

Jan 10, 2018

BUY
$8.15 - $10.55 $45,379 - $58,742
5,568 Added 2.33%
244,294 $1.99 Million
Q3 2017

Oct 06, 2017

BUY
$10.45 - $11.44 $2.49 Million - $2.73 Million
238,726
238,726 $2.5 Million

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $32.2M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Corrado Advisors, LLC Portfolio

Follow Corrado Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corrado Advisors, LLC with notifications on news.